1 active not recruiting, 1 recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Recruiting 1 |
Follow Osteosarcoma in Children: new trials by email Literature Review of Osteosarcoma in Children trials Research Report on Osteosarcoma in Children
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma Tegavivint, Gemcitabine - Osteosarcoma Recurrent, Osteosarcoma in Children | Phase 1 | Recruiting | Emory University | 24 | 2026-01-22 | 2026-10-19 |
| Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma Nivolumab, Azacitidine, Post Treatment Surgery - Osteosarcoma, Osteosarcoma in Children | Phase 1 | Active not recruiting | H. Lee Moffitt Cancer Center and Research Institute | 21 | 2019-10-03 | 2026-07-30 |
Osteosarcoma (2) · Sarcoma (1)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Bone Tissue (2) · Neoplasms, Connective Tissue (2) · Neoplasms, Connective and Soft Tissue (2) · Sarcoma (1)
Azacitidine (1) · Gemcitabine (1) · Nivolumab (1) · Standard of Care (1)
Emory University (1) · H. Lee Moffitt Cancer Center and Research Institute (1)
United States (2)
Mihaela M Druta, MD (1) · Patrick A. Thompson, MD (1) · Thomas Cash, MD, MSc (1)